Pfam Domains GO Terms
| Hormone 2 |
| negative regulation of acute inflammatory response to non-antigenic stimulus |
| pituitary adenylate cyclase activating polypeptide activity |
| pituitary adenylate cyclase-activating polypeptide receptor binding |
| regulation of somatostatin secretion |
| positive regulation of somatostatin secretion |
| regulation of acute inflammatory response to non-antigenic stimulus |
| positive regulation of chemokine (C-C motif) ligand 5 production |
| negative regulation of acute inflammatory response to antigenic stimulus |
| histamine secretion |
| histamine transport |
| regulation of oligodendrocyte progenitor proliferation |
| positive regulation of growth hormone secretion |
| regulation of chemokine (C-C motif) ligand 5 production |
| peptide hormone receptor binding |
| negative regulation of acute inflammatory response |
| negative regulation of inflammatory response to antigenic stimulus |
| regulation of acute inflammatory response to antigenic stimulus |
| regulation of growth hormone secretion |
| negative regulation of glial cell proliferation |
| azole transport |
| positive regulation of cAMP-mediated signaling |
| regulation of inflammatory response to antigenic stimulus |
| neuropeptide hormone activity |
| behavioral fear response |
| regulation of glial cell proliferation |
| behavioral defense response |
| positive regulation of synaptic transmission, glutamatergic |
| negative regulation of potassium ion transport |
| fear response |
| negative regulation of muscle cell apoptotic process |
| insulin secretion |
| activation of adenylate cyclase activity |
| negative regulation of gliogenesis |
| pituitary gland development |
| regulation of acute inflammatory response |
| negative regulation of GTPase activity |
| regulation of cAMP-mediated signaling |
| terminal bouton |
| ovarian follicle development |
| ammonium transport |
| cellular response to glucocorticoid stimulus |
| positive regulation of chemokine production |
| positive regulation of blood vessel diameter |
| peptide hormone secretion |
| cellular response to corticosteroid stimulus |
| regulation of muscle cell apoptotic process |
| multicellular organismal response to stress |
| regulation of synaptic transmission, glutamatergic |
| hormone secretion |
| sensory perception of pain |
| diencephalon development |
| regulation of chemokine production |
| hormone transport |
| regulation of neural precursor cell proliferation |
| female gonad development |
| development of primary female sexual characteristics |
| positive regulation of interleukin-6 production |
| regulation of potassium ion transport |
| positive regulation of peptide hormone secretion |
| positive regulation of cold-induced thermogenesis |
| regulation of postsynaptic membrane potential |
| neuropeptide signaling pathway |
| female sex differentiation |
| regulation of gliogenesis |
| endocrine system development |
| response to ethanol |
| positive regulation of hormone secretion |
| adenylate cyclase-activating G protein-coupled receptor signaling pathway |
| perikaryon |
| negative regulation of inflammatory response |
| regulation of blood vessel diameter |
| regulation of tube diameter |
| regulation of interleukin-6 production |
| regulation of tube size |
| regulation of G protein-coupled receptor signaling pathway |
| regulation of cold-induced thermogenesis |
| response to glucocorticoid |
| negative regulation of ion transport |
| cAMP-mediated signaling |
| negative regulation of immune response |
| positive regulation of synaptic transmission |
| protein secretion |
| establishment of protein localization to extracellular region |
| response to corticosteroid |
| protein localization to extracellular region |
| signal release |
| vascular process in circulatory system |
| cyclic-nucleotide-mediated signaling |
| peptide secretion |
| neurotransmitter transport |
| female pregnancy |
| cellular response to steroid hormone stimulus |
| response to starvation |
| ATP metabolic process |
| negative regulation of defense response |
| adenylate cyclase-modulating G protein-coupled receptor signaling pathway |
| gonad development |
| regulation of peptide hormone secretion |
| positive regulation of ERK1 and ERK2 cascade |
| multi-multicellular organism process |
| development of primary sexual characteristics |
| response to alcohol |
| G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger |
| sex differentiation |
| regulation of hormone secretion |
| positive regulation of neuron projection development |
| positive regulation of cytosolic calcium ion concentration |
| positive regulation of peptide secretion |
| negative regulation of neurogenesis |
| regulation of ERK1 and ERK2 cascade |
| response to antibiotic |
| negative regulation of nervous system development |
| neuron projection |
| response to steroid hormone |
| regulation of cytosolic calcium ion concentration |
| negative regulation of cell development |
| signaling receptor binding |
| regulation of inflammatory response |
| second-messenger-mediated signaling |
| negative regulation of response to external stimulus |
| positive regulation of neuron differentiation |
| positive regulation of cell projection organization |
| forebrain development |
| regulation of metal ion transport |
| blood circulation |
| circulatory system process |
| positive regulation of secretion by cell |
| gland development |
| positive regulation of GTPase activity |
| reproductive structure development |
| reproductive system development |
| regulation of membrane potential |
| positive regulation of secretion |
| cellular calcium ion homeostasis |
| negative regulation of immune system process |
| modulation of chemical synaptic transmission |
| regulation of trans-synaptic signaling |
| calcium ion homeostasis |
| positive regulation of cytokine production |
| negative regulation of hydrolase activity |
| cellular divalent inorganic cation homeostasis |
| positive regulation of neurogenesis |
| regulation of GTPase activity |
| negative regulation of transport |
| divalent inorganic cation homeostasis |
| regulation of peptide secretion |
| regulation of neuron projection development |
| response to nutrient levels |
| response to toxic substance |
| regulation of anatomical structure size |
| cellular response to lipid |
| response to extracellular stimulus |
| positive regulation of protein kinase activity |
| regulation of hormone levels |
| positive regulation of nervous system development |
| cellular response to organic cyclic compound |
| positive regulation of cell development |
| positive regulation of MAPK cascade |
| cellular metal ion homeostasis |
| behavior |
| negative regulation of cell cycle |
| positive regulation of kinase activity |
| cellular response to hormone stimulus |
| metal ion homeostasis |
| cellular cation homeostasis |
| cellular ion homeostasis |
| positive regulation of transferase activity |
| regulation of neuron differentiation |
| neuron projection development |
| developmental process involved in reproduction |
| negative regulation of cell population proliferation |
| regulation of cytokine production |
| regulation of plasma membrane bounded cell projection organization |
| regulation of ion transport |
| cation homeostasis |
| regulation of cell projection organization |
| negative regulation of cell differentiation |
| inorganic ion homeostasis |
| regulation of peptide transport |
| brain development |
| cellular chemical homeostasis |
| regulation of secretion by cell |
| regulation of MAPK cascade |
| regulation of defense response |
| positive regulation of hydrolase activity |
| head development |
| ion homeostasis |
| negative regulation of catalytic activity |
| regulation of protein kinase activity |
| regulation of secretion |
| neuron development |
| regulation of neurogenesis |
| cation transport |
| response to lipid |
| regulation of kinase activity |
| negative regulation of apoptotic process |
| cellular homeostasis |
| negative regulation of programmed cell death |
| response to hormone |
| positive regulation of cell population proliferation |
| response to organic cyclic compound |
| regulation of nervous system development |
| regulation of cell development |
| negative regulation of developmental process |
| positive regulation of cell differentiation |
| sensory perception |
| regulation of transferase activity |
| central nervous system development |
| positive regulation of transport |
| negative regulation of cell death |
| multi-organism reproductive process |
| secretion by cell |
| neuron differentiation |
| positive regulation of protein phosphorylation |
| response to drug |
| positive regulation of intracellular signal transduction |
| regulation of protein localization |
| export from cell |
| positive regulation of phosphorylation |
| regulation of response to external stimulus |
| chemical homeostasis |
| cell-cell signaling |
| plasma membrane bounded cell projection organization |
| secretion |
| positive regulation of phosphorus metabolic process |
| positive regulation of phosphate metabolic process |
| negative regulation of molecular function |
| regulation of immune response |
| cell projection organization |
| regulation of cell cycle |
| negative regulation of multicellular organismal process |
| positive regulation of cellular component organization |
| positive regulation of transcription by RNA polymerase II |
| cellular response to endogenous stimulus |
| positive regulation of protein modification process |
| regulation of hydrolase activity |
| G protein-coupled receptor signaling pathway |
| defense response |
| positive regulation of developmental process |
| ion transport |
| nervous system process |
| reproductive process |
| reproduction |
| positive regulation of catalytic activity |
| regulation of protein phosphorylation |
| response to endogenous stimulus |
| regulation of response to stress |
| protein transport |
| generation of neurons |
| peptide transport |
| regulation of apoptotic process |
| positive regulation of transcription, DNA-templated |
| response to oxygen-containing compound |
| regulation of programmed cell death |
| amide transport |
| regulation of phosphorylation |
| extracellular space |
| positive regulation of cellular protein metabolic process |
| establishment of protein localization |
| regulation of cell population proliferation |
| negative regulation of response to stimulus |
| neurogenesis |
| positive regulation of nucleic acid-templated transcription |
| positive regulation of RNA biosynthetic process |
| homeostatic process |
| cell development |
| regulation of immune system process |
| positive regulation of signal transduction |
| regulation of cell death |
| intracellular signal transduction |
| positive regulation of protein metabolic process |
| positive regulation of RNA metabolic process |
| positive regulation of multicellular organismal process |
| positive regulation of molecular function |
| regulation of phosphate metabolic process |
| regulation of phosphorus metabolic process |
| regulation of cell differentiation |
| positive regulation of cell communication |
| positive regulation of signaling |
| regulation of intracellular signal transduction |
| nitrogen compound transport |
| regulation of protein modification process |
| regulation of transport |
| positive regulation of nucleobase-containing compound metabolic process |
| positive regulation of macromolecule biosynthetic process |
| extracellular region |
| system process |
| positive regulation of cellular biosynthetic process |
| positive regulation of gene expression |
| positive regulation of biosynthetic process |
Compound Hit Most Correlated Genes in Chemogenomics Tissues where Essential in the Avana Dataset (DepMap 20Q1)
| Tissue | Fraction Of Cell Lines Where Essential |
|---|---|
| 1290807.0 | 0/1 |
| 909776.0 | 0/1 |
| bile duct | 0/28 |
| blood | 0/28 |
| bone | 0/26 |
| breast | 0/33 |
| central nervous system | 0/56 |
| cervix | 0/4 |
| colorectal | 0/17 |
| esophagus | 0/13 |
| fibroblast | 0/1 |
| gastric | 0/16 |
| kidney | 0/21 |
| liver | 0/20 |
| lung | 0/75 |
| lymphocyte | 0/16 |
| ovary | 0/26 |
| pancreas | 0/24 |
| peripheral nervous system | 0/16 |
| plasma cell | 0/15 |
| prostate | 0/1 |
| skin | 0/24 |
| soft tissue | 0/9 |
| thyroid | 0/2 |
| upper aerodigestive | 0/22 |
| urinary tract | 0/29 |
| uterus | 0/5 |
Expression Distribution